AI
Startup Evvy raises $40M to accelerate precision diagnostics and medicine for women’s health
Women's healthcare startup Evvy (Allora Health Inc.) has raised $40 million in Series B funding led by Catalio Capital Management.
Key takeaways
- Evvy raised $40 million in Series B funding led by Catalio Capital Management.
- EvvyAI analyzes metagenomic sequencing data from at-home swabs to match patients with personalized prescription treatment plans.
- Licensed clinicians using EvvyAI report successfully diagnosing more than 90% of symptomatic patients.
- Evvy has identified six distinct subtypes of bacterial vaginosis (BV) through microbiome analysis.
- The company has served more than 100,000 patients across 3,000 medical practitioners.
Women's healthcare startup Evvy (Allora Health Inc.) has raised $40 million in Series B funding led by Catalio Capital Management. The company uses its machine learning engine, EvvyAI, alongside at-home metagenomic sequencing kits to analyze the vaginal microbiome and generate personalized prescription treatment plans. Evvy has already served over 100,000 patients across 3,000 medical practitioners and plans to use the new capital to expand its AI-enabled diagnostic models into fertility issues.
The funding accelerates AI-driven precision diagnostics to close historical research gaps in female biology.
In their words
“Women hear ‘unexplained’ constantly, whether it’s unexplained infertility, unexplained recurrence, unexplained pain. It’s stated like a diagnosis, when it really means medicine wasn’t built to measure female biology.”
“For a long time, women were considered to be “small men,” from a medical and research standpoint, erasing the many ways that the female body is distinct, down to the cellular level.”
By the numbers
- $40M
- Series B funding raised by Evvy
- 50%
- Misdiagnosis rates for some women's health conditions
- 60%
- Recurrence rate of common vaginal symptoms
- 100,000
- Patients served by Evvy so far
- 3,000
- Medical practitioners using Evvy's technology
How it unfolded
- Clinical trials of new drugs generally excluded women
- Evvy announces $40 million Series B funding round
Turn stories like this into views
Ravenclip finds the AI news, makes the video, and posts it before attention moves on.
Common questions
- What happened with Evvy?
- Evvy raised $40 million in Series B funding led by Catalio Capital Management.
- Where can I read the original report?
- Read the full report at Siliconangle.
